Novel transcript, antisense to ADAMTSL1 (ENSG00000304884)

This target is a long noncoding RNA gene (lncRNA) transcribed in the antisense direction relative to the ADAMTSL1 locus on human chromosome 9[1][6]. It is not a protein-coding gene and does not function as an enzyme, receptor, transporter, or classical therapeutic target. Antisense transcripts such as this often regulate the expression of their sense counterparts (in this case, ADAMTSL1) through mechanisms including chromatin modification, transcriptional interference, RNA masking, and modulation of mRNA stability[2][4]. There is currently no evidence for a direct role of this antisense transcript in disease, drug interaction, safety concerns, or use as a biomarker. Its biological significance is inferred from broader studies of antisense lncRNAs, which are increasingly recognized for their contribution to gene regulatory networks, but detailed functional characterization of ENSG00000304884 is lacking in public databases[1][6].

Other names

LOC102724102Novel transcript, antisense to ADAMTSL1ENSG00000304884

Not applicable; general mechanisms for antisense transcripts include chromatin remodeling, transcriptional interference, RNA masking, and dsRNA-dependent regulation[2][4] No known drug-specific mechanisms